A group of researchers led by Liesbeth de Vries of the UMCG (UMC Groningen), Guus van Dongen (Amsterdam UMC), John Haanen (NKI/AVL), and Peter de With (TU/e) has joined forces in the FORESIGHT consortium. This consortium will receive a grant of no less than €9 million from Health~ Holland to conduct research in the field of drug development supported by molecular imaging.
The new FORESIGHT consortium will stimulate research that will improve the use and development of immunotherapy. These relatively new drugs are now hugely successful in tackling severe conditions. These include oncological, autoimmune, cardiovascular, and neurodegenerative diseases.
More information
Check the webpage.